Abstract
CardioVascular (CV) Disease (CVD) accounts for 25% of all UK deaths [1-4]. Before developing and applying new or existing CV risk prediction tools [5-22] for prediction of incident CVD events, it is important to have a description of the baseline characteristics of the patients who experienced a myocardial Infarction (MI) event. This paper presents the baseline characteristics of a cohort of patients who experienced a first MI between 1st of January 2006 and 31st of December 2014 in England, UK, age equal or greater than 35 years
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author would like to thank to the Heart Research UK Translation Research Project Grants for supporting this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the CPRD Independent Scientific Advisory Committee (protocol number 20-177). Generic ethical approval for observational research using CPRD with approval from ISAC has been granted by a Health Research Authority (HRA) Research Ethics Committee (East Midlands Derby, REC reference number 05/MRE04/87).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Abstract shown initially in the Health Services Research (HSR) UK conference 2021.
Data Availability
Data is not available.
